Form 4: Heartflow Director Sells 8,000 Shares Under 10b5-1 Plan
Insider Transaction Report
Heartflow Director Julie A. Cullivan sold 8,000 shares of common stock at $27.32 per share pursuant to a pre-arranged Rule 10b5-1 trading plan.
Summary
- Julie A. Cullivan, a Director of Heartflow, Inc. (HTFL), disposed of 8,000 shares of common stock.
- The transaction occurred on February 5, 2026, at a price of $27.32 per share.
- The sale was executed under a Rule 10b5-1 trading plan, which was adopted by Ms. Cullivan on September 12, 2025.
- Following this transaction, Ms. Cullivan beneficially owns 36,413 shares of Heartflow common stock directly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While an insider sale can sometimes be a negative signal, the execution under a 10b5-1 plan mitigates concerns, suggesting a planned financial move rather than a reaction to adverse company news.
Negatives
- A director selling shares could be perceived negatively by some investors, although the sale was pre-planned.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 trading plan, are common for purposes such as personal financial planning, diversification, or liquidity. These pre-scheduled transactions typically do not reflect new material non-public information about the company's performance or future prospects, distinguishing them from unplanned insider sales.
Stakeholder Impact
- Shareholders: May observe the director's sale, but the 10b5-1 plan suggests it's a routine event rather than a signal of declining company prospects.
Key Dates
| Date | Description |
|---|---|
| 09/12/2025 | Rule 10b5-1 trading plan adopted by Reporting Person. |
| 02/05/2026 | Date of transaction (sale of common stock). |
| 02/06/2026 | Signature date of the Form 4 filing. |
Recommendation
holdThe sale by a director, while notable, was conducted under a pre-established 10b5-1 trading plan. This indicates a planned diversification or liquidity event rather than a reaction to new material information. This type of transaction generally does not alter the fundamental investment thesis for the company, thus a 'hold' recommendation is appropriate.
Keywords
Heartflow, HTFL, Insider Sale, Form 4, Director Transaction, 10b5-1 Plan, Julie Cullivan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.